Macrophages may play critical role in melanoma resistance to BRAF inhibitors
3/19/2015
With targeted therapies no longer viewed as a 'magic bullet' for cancer treatment, this study suggests that macrophages could be a new therapeutic target for patients with melanomaIn the last...
Microenvironment provides growth factor for metastasis of neuroblastoma
3/19/2015
Investigators identify new role for cytokine VEGFA in the metastasis of neuroblastomaHealthy bone is continuously involved in a dynamic process that includes bone deposition and bone resorption.
How rocket science may improve kidney dialysis
3/19/2015
Software from the aerospace industry has allowed an interdisciplinary team of UK researchers to design Arterio-Venous Fistulae with better, less unnatural flow patternsStreamlines of flow...
Study identifies 'lethal' subtype of prostate cancer
3/19/2015
7,500 deaths per year possibly due to MAP3K7-CHD1 lossA University of Colorado Cancer Center study published in the journal Cancer Research defines a new, distinct subtype of "lethal" prostate...
Predicting prostate cancer
3/19/2015
Nanotechnology shows promise for more accurate prostate cancer screening and prognosisA Northwestern University-led study in the emerging field of nanocytology could one day help men make better...
Investigators find window of vulnerability for STIs to infect female reproductive tract
3/19/2015
Findings apply to challenges in gynecological cancers such as cervical cancerCharles R.
Trial of bivalirudin during angioplasty reports mixed results
3/19/2015
Anticoagulant fails to meet primary endpoints but may reduce bleeding and deathPatients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not...
Novartis has announced that the European Commission has approved Jakavi® (ruxolitinib) for the treatment of adult patients with polycythemia vera (PV) who are resistant to or intolerant of...
Scripps Florida scientists confirm key targets of new anti-cancer drug candidates
3/18/2015
Ribosomes, ancient molecular machines that produce proteins in cells, are required for cell growth in all organisms, accomplishing strikingly complex tasks with apparent ease.
In a new study that could help improve the day-to-day quality-of-life for women with breast cancer, UCLA researchers have developed a cognitive rehabilitation program to address post-cancer...